Company / Working Capital per Share
Pfizer Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$1.04
FY2025
5-year range
-$0.78 / $3.00
FY2021-FY2025
Trend
-19.3%
vs FY2024
Sector context
#176 of 210
Health Care
What the data says
Pfizer's working capital per share of $1.04 is lower than 84% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 10 years, ranging from $-0.78 in FY2023 to $3.00 in FY2021.
Based on SEC 10-K filings.
1.04 in FY2025 with a 5-year CAGR of -7.5%.
Improved from $-0.78 to $1.04 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -13.8%
- 5-Year CAGR
- -7.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 210This company $1.04 Sector average $146.86
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 19.3% year-over-year.
- Ranks #176 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.04 | -19.3% |
| FY2024 | $1.28 | +264.3% |
| FY2023 | -$0.78 | -148.3% |
| FY2022 | $1.62 | -46.0% |
| FY2021 | $3.00 | +96.0% |
| FY2020 | $1.53 | +306.0% |
| FY2019 | -$0.74 | -125.3% |
| FY2018 | $2.93 | +71.3% |
| FY2017 | $1.71 | +40.4% |
| FY2016 | $1.22 | -41.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026